Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1991
11/12/1991WO1991017761A1 Targeted protection from cytotoxins
11/12/1991US5064942 New protein tetranectin isolated from human blood
11/12/1991US5064939 Cyclic gnrh antagonists
11/12/1991US5064814 Anti-thrombotic peptide and pseudopeptide derivatives
11/12/1991US5064813 Antiandrogen, antiestrogen, steroid inhibitor
11/12/1991US5064811 De-mannosyl teicoplanin derivatives
11/12/1991US5064810 Use of branched chain amino acids to effect diaphragm contractility and fatigue
11/12/1991US5064655 Liposome gel composition and method
11/12/1991US5064648 Use of Bacillus thuringiensis microbe for controlling lesser mealworm, Alphitobius diaperinus
11/12/1991US5064646 In poultry, which will not bind to monoclonal antibodies that bind to current vaccines; live or killed vaccines
11/12/1991US5064645 Hyperimmune composition for passive immunization of fishes against furunculosis caused by Aeromonas salmonicida
11/12/1991US5064643 Method for treating sickle cell disease
11/12/1991US5064430 Polynonapeptide bioelastomers having an increased elastic modulus
11/12/1991CA2082637A1 Process for producing protein
11/12/1991CA2082507A1 Targeted protection from cytotoxins
11/12/1991CA2041825A1 Renin inhibitors
11/11/1991WO1991017258A1 Inhibitors of factor xii activation and applications thereof
11/11/1991WO1991017250A1 Method for the recombinant production of hiridius and hirudin-like polypeptides
11/11/1991CA2082643A1 Inhibitors of factor xii activation and applications thereof
11/11/1991CA2063575A1 Method for the recombinant production of hirudins and hirudin-like polypeptides
11/10/1991WO1991016915A1 Maturation of hemopoietic cells
11/10/1991CA2056359A1 Maturation of hemopoietic cells
11/09/1991CA2041439A1 Muteins of the granulocyte colony stimulating factor (g-csf)
11/08/1991WO1991017440A1 Improved method for radiolabeling monovalent antibody fragments
11/08/1991CA2082265A1 Method for radiolabeling monovalent antibody fragments
11/06/1991EP0455432A1 Alpha-glycosyl naringin, and its preparation and uses
11/06/1991EP0455422A2 Method of treating or preventing baldness with compositions containing fibroblast growth factor
11/06/1991EP0455133A2 Peptide antagonists of bradykinin
11/06/1991EP0455093A2 Use of a tumor necrosis factor for facilitating nerve regeneration
11/06/1991EP0454898A1 Glycosaminoglycan-modified protein, process for the production of this protein, use and pharmaceutical compositions containing the same
11/06/1991EP0454813A1 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract
11/06/1991EP0454767A1 Compositions and methods for treating or preventing aids, arc and hiv infection
11/06/1991EP0454765A1 Pregnancy specific proteins applications
11/06/1991EP0454736A1 Fibrinolysis by il-4
11/06/1991EP0454733A1 Osmotically dependent vesicles
11/06/1991EP0454730A1 Somatotropin analogs
11/06/1991EP0203107B1 Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
11/06/1991CN1055879A Antibody conjugates for treatment of neoplastic disease
11/06/1991CN1055876A Inhibitors of advanced glycosylation of proteins and method of use therefor
11/06/1991CA2041817A1 Amino acid derivatives
11/05/1991WO1991017186A1 Beta cell antigen
11/05/1991WO1991017170A1 Multimeric gelsolin fusion constructs
11/05/1991WO1991016923A1 Novel synthetic grf analogs
11/05/1991US5063210 Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
11/05/1991US5063209 Modulation of aids virus-related events by double-stranded RNAs
11/05/1991US5063206 Compositions having use as treatment of neuropsychiatric deficits
11/05/1991US5063205 Epidermal growth factor
11/05/1991US5063204 Process for treating infertility
11/05/1991US5063203 Anticoagulants, humans
11/05/1991US5063150 Immunology
11/05/1991US5063064 Lithium fluoride
11/05/1991US5063053 Isolation and purification of the R18 antigen of HTLV-III
11/05/1991CA2082162A1 Beta cell antigen
11/05/1991CA2082059A1 Synthetic grf analogs
11/05/1991CA2063593A1 Multimeric gelsolin fusion constructs
11/05/1991CA2041742A1 Stabilization of somatotropins and other proteins by modification of cysteine residues
11/05/1991CA1291708C Solubilization of proteins for pharmaceutical compositions using polymer conjugation
11/05/1991CA1291706C COMBINATION THERAPY USING INTERFERON-.beta. AND INTERLEUKIN-2
11/03/1991WO1991016894A1 Quinolizinone type compounds
10/1991
10/31/1991WO1991016437A1 Soluble peptide analogues containing binding sites
10/31/1991WO1991016430A1 NOVEL T-CELL LYMPHOMA cDNA CLONES
10/31/1991WO1991016427A1 Methods for phenotype creation from multiple gene populations
10/31/1991WO1991016420A1 Methods of preventing viral replication
10/31/1991WO1991016355A1 Method for increasing blood-brain barrier permeability
10/31/1991WO1991016354A1 Processes and intermediates for synthetic antibody derivatives
10/31/1991WO1991016353A1 Thrombus-specific antibody derivatives
10/31/1991WO1991016349A1 Expression of recombinant hemoglobin in yeast
10/31/1991WO1991016347A1 Composition for macrophage activation
10/31/1991WO1991016346A1 Glycopeptides antibiotics
10/31/1991WO1991016343A1 (hyp 9) lhrh, its derivatives or fragments, production method and uses as a drug or in an assay
10/31/1991WO1991016342A1 Novel physiologically active peptide originating in hog
10/31/1991WO1991016340A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
10/31/1991WO1991016339A1 Inhibitors of dipeptidyl-aminopeptidase type iv
10/31/1991WO1991016338A1 S-(lower fatty acid)-substituted glutathione derivative
10/31/1991WO1991016337A1 S-(lower fatty acid)-substituted glutathione derivative
10/31/1991WO1991016335A1 Glycosylated pdgf
10/31/1991WO1991016324A1 Novel cc-1065 analogs
10/31/1991WO1991016082A1 Decontaminated biological material
10/31/1991WO1991016074A1 Administration of monoclonal antibodies against respiratory viruses
10/31/1991WO1991016071A1 Antibody conjugates for treatment of neoplastic disease
10/31/1991WO1991016070A1 Enzymatic disinsertion of vitreous body
10/31/1991WO1991016069A1 Selective cytotoxic reagents comprising toxic moieties derived from mammalian proteins
10/31/1991WO1991016068A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
10/31/1991WO1991016066A1 Composition and treatment with biologically active peptides and toxic cations
10/31/1991WO1991016065A1 Hepatic disorder inhibitor
10/31/1991WO1991016060A1 Method of inactivation of viral and bacterial blood contaminants
10/31/1991WO1991016038A1 Pharmaceutical aerosol formulation of solid polypeptide microparticles and method for the preparation thereof
10/31/1991WO1991016031A1 Psoriasis treatment
10/31/1991WO1991013984A3 Interleukin-4 binding proteins
10/31/1991WO1991009118A3 Activatable fibrinolytic and anti-thrombotic proteins
10/31/1991DE4037604A1 Use of anti-TNF antibodies to treat ischaemia and its sequelae - esp. to increase survival rate after myocardial infarct and transplants
10/31/1991DE4013910A1 Combination preparation for immunosuppressive therapy - contains prostacyclin which increases utility of cyclosporin A in preventing organ rejection in transplant therapy
10/31/1991CA2081308A1 Method for increasing blood-brain barrier permeability
10/31/1991CA2081207A1 Soluble peptide analogues containing binding sites
10/31/1991CA2081022A1 Methods of preventing viral replication
10/31/1991CA2080589A1 Expression of recombinant hemoglobin in yeast
10/31/1991CA2080474A1 Inhibitors of dipeptidyl-aminopeptidase type iv
10/31/1991CA2060210A1 Glutathione-s-lower fatty acid derivative
10/31/1991CA2060209A1 Glutathione-s-lower fatty acid derivative
10/31/1991CA2060200A1 Antihepatopathic composition
1 ... 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 ... 3163